René‐Marc Flipo

8.8k total citations
212 papers, 4.7k citations indexed

About

René‐Marc Flipo is a scholar working on Rheumatology, Surgery and Hematology. According to data from OpenAlex, René‐Marc Flipo has authored 212 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Rheumatology, 46 papers in Surgery and 38 papers in Hematology. Recurrent topics in René‐Marc Flipo's work include Rheumatoid Arthritis Research and Therapies (104 papers), Spondyloarthritis Studies and Treatments (35 papers) and Autoimmune and Inflammatory Disorders Research (35 papers). René‐Marc Flipo is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (104 papers), Spondyloarthritis Studies and Treatments (35 papers) and Autoimmune and Inflammatory Disorders Research (35 papers). René‐Marc Flipo collaborates with scholars based in France, United States and Switzerland. René‐Marc Flipo's co-authors include B Duquesnoy, Bernard Cortet, Anne Cotten, Bernard Combe, B Delcambre, Thomas Bardin, Thierry Schaeverbeke, Jean Sibilia, Xavier Le Loët and Xavier Mariette and has published in prestigious journals such as Gastroenterology, Scientific Reports and Radiology.

In The Last Decade

René‐Marc Flipo

198 papers receiving 4.5k citations

Peers

Countries citing papers authored by René‐Marc Flipo

Since Specialization

Citations

This map shows the geographic impact of René‐Marc Flipo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René‐Marc Flipo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René‐Marc Flipo more than expected).

Fields of papers citing papers by René‐Marc Flipo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René‐Marc Flipo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René‐Marc Flipo. The network helps show where René‐Marc Flipo may publish in the future.

Co-authorship network of co-authors of René‐Marc Flipo

This figure shows the co-authorship network connecting the top 25 collaborators of René‐Marc Flipo. A scholar is included among the top collaborators of René‐Marc Flipo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René‐Marc Flipo. René‐Marc Flipo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie 2023 ·Clinical and Experimental Rheumatology ·(unknown), Anastas Batalov, Dimitrios T. Boumpas, Salvatore D’Angelo, Filip De Keyser, René‐Marc Flipo, (unknown), (unknown), Ahmed Mahmoud	1
2	Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study 2023 ·Lara D. Veeken ·(unknown), (unknown), Daniel Wendling, Peggy Philippe, (unknown), C. Roux, Philippe Dieudé, (unknown), Jérôme Avouac, (unknown), Éric Houvenagel, Jérémie Sellam, Bernard Cortet, Julien Henry, René‐Marc Flipo, Valérie Devauchelle‐Pensec	6
3	Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis 2022 ·Arthritis Research & Therapy ·Johanna Sigaux, Sylvain Mathieu, Yann Nguyen, (unknown), Jean-Guillaume Letarouilly, Martin Soubrier, Sébastien Czernichow, René‐Marc Flipo, Jérémie Sellam, C. Daïen	30
4	Serum Fatty Acid Profiles Are Associated with Disease Activity in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort 2022 ·Nutrients ·Johanna Sigaux, Alice Bellicha, Camille Buscail, Chantal Julia, René‐Marc Flipo, Alain Cantagrel, François Laporte, (unknown), Marie‐Christophe Boissier, Luca Semerano	6
5	Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings 2022 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), (unknown), Éric Houvenagel, X. Deprez, Peggy Philippe, Tristan Pascart, René‐Marc Flipo, Vincent Goëb, Jean-Guillaume Letarouilly	10
6	Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP) 2022 ·Annals of the Rheumatic Diseases ·Yvette Meißner, Anja Strangfeld, Anna Moltó, Frauke Förger, Marianne Wallenius, N. Costedoat‐Chalumeau, (unknown), Marion Couderc, René‐Marc Flipo, G. Guettrot-Imbert, Isabell Haase, (unknown), (unknown), Christophe Richez, Jérémie Sellam, Anja Weiß, Astrid Zbinden, Rebecca Fischer‐Betz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	14
7	COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study 2022 ·Journal of Autoimmunity ·Matheus Vieira, Cloé Comarmond, Julien Labreuche, Adrien Mirouse, David Saadoun, Christophe Richez, René‐Marc Flipo, É. Hachulla, Élodie Drumez, P. Cacoub	6
8	OP0180 IMPACT OF RF AND ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS ON 2-YEAR RETENTION OF ABATACEPT IN PATIENTS WITH RA 2021 ·Annals of the Rheumatic Diseases ·Rieke Alten, Xavier Mariette, René‐Marc Flipo, Roberto Caporali, (unknown), (unknown), Raimón Sanmartí, Sara Marsal, Michael T. Nurmohamed, Hedley Griffiths, P. Peichl, Bettina Bannert, Adrian Forster, M. Chartier, Seán Connolly, Yedid Elbez, C. Rauch, Vadim Khaychuk, (unknown)	0
9	Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases 2021 ·Joint Bone Spine ·C. Daïen, Sébastien Czernichow, Jean-Guillaume Letarouilly, Yann Nguyen, (unknown), Johanna Sigaux, Catherine Beauvais, (unknown), (unknown), Vincent Rigalleau, Pauline Rivière, Monique Romon, Luca Semerano, Raphaèle Séror, (unknown), Anne Tournadre, (unknown), Daniel Wendling, René‐Marc Flipo, Jérémie Sellam	36
10	2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy 2020 ·Joint Bone Spine ·Tristan Pascart, Augustin Latourte, René‐Marc Flipo, Gérard Chalès, (unknown), Alain Cohen‐Solal, Hang‐Korng Ea, (unknown), Emmanuel Letavernier, Frédéric Lioté, Sébastien Ottaviani, Pierre Sigwalt, (unknown), Pascal Richette, Thomas Bardin	44
11	Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study 2019 ·BMJ ·Jacques‐Eric Gottenberg, Jacques Morel, Élodie Perrodeau, Thomas Bardin, Bernard Combe, Maxime Dougados, René‐Marc Flipo, Alain Saraux, Thierry Schaeverbeke, Jean Sibilia, Martin Soubrier, Olivier Vittecoq, Gabriel Baron, Arnaud Constantin, Philippe Ravaud, Xavier Mariette	93
12	SAT0629 THERE ARE 4 MAIN QUESTIONNAIRES TO ASSESS ADHERENCE IN INFLAMMATORY ARTHRITIS BUT NONE OF THEM PERFORM WELL: A SYSTEMATIC LITERATURE REVIEW 2019 ·Annals of the Rheumatic Diseases ·(unknown), Xavier Romand, (unknown), Anna Moltó, René‐Marc Flipo, Christophe Richez, Alain Saraux, Loriane Gutermann, (unknown), Maxime Dougados, Laure Gossec	3
13	Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers 2016 ·Joint Bone Spine ·Pierre‐Antoine Juge, Marie‐Elise Truchetet, Évangéline Pillebout, Sébastien Ottaviani, Cécile Vigneau, (unknown), Divi Cornec, Tristan Pascart, Renaud Snanoudj, (unknown), Émilie Cornec-Le Gall, Thierry Schaeverbeke, Alain Saraux, Philippe Dieudé, René‐Marc Flipo, Pascal Richette, Frédéric Lioté, Thomas Bardin, Gérard Chalès, Hang‐Korng Ea	34
14	Treatment of Nongout Joint Deposition Diseases: An Update 2014 ·PubMed ·Tristan Pascart, Pascal Richette, René‐Marc Flipo	8
15	Association of Anticyclic Citrullinated Peptide Antibodies and/or Rheumatoid Factor Status and Clinical Presentation in Early Arthritis: Results from the ESPOIR Cohort 2014 ·The Journal of Rheumatology ·Gaël Mouterde, Cédric Lukas, Philippe Goupille, René‐Marc Flipo, Nathalie Rincheval, Jean‐Pierre Daurès, Bernard Combe	15
16	New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases 2011 ·Seminars in Arthritis and Rheumatism ·Daniel Wendling, Julien Paccou, Jean‐Marie Berthelot, René‐Marc Flipo, S. Guillaume-Czitrom, Clément Prati, Emmanuelle Dernis, Guillaume Direz, (unknown), Jean-Michel Ristori	102
17	Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-α antagonist therapy: safe re-initiation of TNF-α blockers after appropriate anti-tuberculous treatment 2008 ·Clinical Microbiology and Infection ·Bernard Denis, A. Lefort, René‐Marc Flipo, Florence Tubach, Marc Lémann, Philippe Ravaud, Dominique Salmon, Xavier Mariette, Olivier Lortholary	34
18	Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6months' first-line DMARD therapy 2006 ·Joint Bone Spine ·Olivier Meyer, Michel De Bandt, Jean‐Marie Berthelot, Alain Cantagrel, Bernard Combe, Bruno Fautrel, René‐Marc Flipo, Frédéric Lioté, Jean-Françis Maillefert, Alain Saraux, Daniel Wendling, Françis Guillemin, Xavier Le Loët	14
19	Le traitement des spondylodiscites infectieuses non tuberculeuses. Analyse des pratiques thérapeutiques chez 110 patients hospitalisés dans 12 CHU en France 2001 ·Revue du Rhumatisme ·Érick Legrand, René‐Marc Flipo, Philippe Goupille, Xavier Chevalier, A. Cantagrel, Thierry Conrozier	4
20	Paraostéoarthropathie nerveuse des mains. A propos de 2 observations. 1993 ·Revue du Rhumatisme ·René‐Marc Flipo, (unknown), (unknown), F Danzé, (unknown), B Duquesnoy, B Delcambre	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact